Deakin University
Browse

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms

Version 2 2024-06-04, 04:59
Version 1 2022-09-29, 06:32
journal contribution
posted on 2024-06-04, 04:59 authored by Erica Neill, Susan L Rossell, Caitlin Yolland, Denny Meyer, Cherrie Galletly, Anthony Harris, Dan Siskind, Michael BerkMichael Berk, Kiymet Bozaoglu, Frances Dark, Olivia DeanOlivia Dean, Paul FrancisPaul Francis, Dennis Liu, Andrea Phillipou, Jerome Sarris, David J Castle
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms

History

Journal

Schizophrenia Bulletin

Pagination

1-10

Location

Oxford, Eng.

ISSN

0586-7614

eISSN

1745-1701

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Publisher

Oxford University Press